This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman
by Zacks Equity Research
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman
5 Solid High Dividend Value ETFs & Stocks to Buy Now
by Sweta Killa
Nothing seems a better strategy than picking ETFs with a combination of value stocks and higher dividend yields in this kind of an environment.
5 Low Price-to-Book Stocks to Buy in a Volatile Market
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
Are You Looking for a High-Growth Dividend Stock? Manulife Financial (MFC) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Manulife Financial (MFC) have what it takes? Let's find out.
Manulife Financial on Strong Growth Graph: Apt to Hold?
by Zacks Equity Research
Manulife Financial (MFC) promises to reap better returns for investors on the back of six factors.
Why Is Manulife (MFC) Down 3.6% Since Last Earnings Report?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports with Q2 Earnings Analysis: Merck, CVS Health, CME Group & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and CME Group (CME).
Manulife (MFC) Q2 Earnings Improve on Solid Segment Results
by Zacks Equity Research
Double-digit core earnings growth across all operating segments as well as better net income boosts Manulife's (MFC) Q2 results.
Top Stock Reports for Alphabet, General Electric & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), General Electric (GE) and Morgan Stanley (MS).
7 Insurers Poised to Outperform in Q2 on Many Tailwinds
by Tanuka De
We zero in on seven insurance stocks, poised to exceed expectations in Q2 on the back of multiple tailwinds favoring the operating environment.
Why Is Manulife (MFC) Up 4% Since Its Last Earnings Report?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Manulife (MFC) Q1 Earnings Grow on Strong Segmental Results
by Zacks Equity Research
Manulife's (MFC) Q1 reflects high growth in Asia and Global Wealth and Asset Management, improved policyholder experience in Canada and a favorable impact of lower U.S. tax rates.
Manulife (MFC) Down 6.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Horace Mann Rewards Shareholders With 3.6% Dividend Hike
by Zacks Equity Research
Horace Mann (HMN) boosts shareholder value with 3.6% dividend hike to instill investors' confidence in the stock.
Assured Guaranty to Diversify Business, Raises Dividend
by Zacks Equity Research
Assured Guaranty (AGO) strategically chooses to pump resources into varied businesses other than its core financial guaranty business.
Top Analyst Reports for Bristol-Myers, Honda & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Bristol-Myers (BMY), Honda (HMC), and Danaher (DHR).
Manulife (MFC) Q4 Earnings Grow on Strong Asia Business
by Zacks Equity Research
Manulife (MFC) Q4 earnings reflect strong growth in Asia and wealth and asset management businesses.
Top Ranked Income Stocks to Buy for January 23rd
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 23rd:
Why You Shouldn't Bet Against Manulife Financial (MFC) Stock
by Zacks Equity Research
Manulife Financial (MFC) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
Reinsurance Group's Unit to Improve Services With Buyout
by Zacks Equity Research
Reinsurance Group's (RGA) unit recently purchases LOGiQ3 Inc. to enable the acquirer help serve its clients more efficiently and instill a positive change in the insurance industry.
AON Seals Townsend Acquisition, Boosts Investment Business
by Zacks Equity Research
AON continues to follow inorganic strategies to strengthen its leading position in the insurance brokerage market and expand global presence.
Sun Life Financial's (SLF) Unit Closes Excel Funds Buyout
by Zacks Equity Research
Sun Life Financial's (SLF) acquisition of Excel Funds will help it to grow its wealth management business in Canada.
Intercontinental Exchange Completes Buyout, Boosts Portfolio
by Zacks Equity Research
Intercontinental Exchange closes Virtu BondPoint buyout, which in turn is likely to strengthen the company's presence in global bond markets and expand fixed income market solutions.
Enstar Group (ESGR) to Gain From Pavonia Holdings' Sale
by Zacks Equity Research
Enstar Group's (ESGR) sale of Pavonia Holdings will enable the company to focus more on its non-life run off business.
Is Manulife Financial (MFC) a Great Stock for Value Investors?
by Zacks Equity Research
Is Manulife Financial (MFC) a great pick from the value investor's perspective right now? Read on to know more.